Understanding the mechanisms of disease has dramatically shifted our therapeutic strategies and methods of patient stratification when treating asthma. The advent of new clinical biomarkers, differential understanding of phenotypes and endotypes, and the introduction of biologics has come with questions of patient selection and suitability for novel treatment strategies. This activity combines the powerful impact of artistic design, infographic presentation, and scientific expertise to deliver the latest in asthma pathophysiology, disease heterogeneity, and biomarker understanding to help inform optimal treatment selection.
Upon successful completion of this education activity, participants should be better able to:
Past-President, American College of Allergy, Asthma & Immunology
Medical Director, Capital Allergy & Respiratory Disease Center
Featured RMEI CE Activities